Shenzhen - Delayed Quote CNY

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (300452.SZ)

12.72 +0.19 (+1.52%)
At close: 3:04 PM GMT+8
Loading Chart for 300452.SZ
DELL
  • Previous Close 12.53
  • Open 12.32
  • Bid 12.74 x --
  • Ask 12.75 x --
  • Day's Range 12.52 - 12.82
  • 52 Week Range 9.92 - 19.47
  • Volume 3,268,760
  • Avg. Volume 3,038,532
  • Market Cap (intraday) 2.982B
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 18.43
  • EPS (TTM) 0.69
  • Earnings Date --
  • Forward Dividend & Yield 0.25 (2.00%)
  • Ex-Dividend Date May 17, 2023
  • 1y Target Est 18.00

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. The company was founded in 2001 and is based in Huainan, China.

www.shanhe01.com

905

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 300452.SZ

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300452.SZ
10.67%
SSE Composite Index
2.62%

1-Year Return

300452.SZ
28.76%
SSE Composite Index
6.79%

3-Year Return

300452.SZ
7.77%
SSE Composite Index
12.13%

5-Year Return

300452.SZ
39.67%
SSE Composite Index
4.64%

Compare To: 300452.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300452.SZ

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    2.94B

  • Enterprise Value

    2.62B

  • Trailing P/E

    18.16

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.53

  • Price/Book (mrq)

    3.53

  • Enterprise Value/Revenue

    3.20

  • Enterprise Value/EBITDA

    14.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.47%

  • Return on Assets (ttm)

    7.56%

  • Return on Equity (ttm)

    19.83%

  • Revenue (ttm)

    819.69M

  • Net Income Avi to Common (ttm)

    159.61M

  • Diluted EPS (ttm)

    0.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    612.23M

  • Total Debt/Equity (mrq)

    32.65%

  • Levered Free Cash Flow (ttm)

    41.64M

Research Analysis: 300452.SZ

Analyst Price Targets

18.00
18.00 Average
12.72 Current
18.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: 300452.SZ

People Also Watch